Harpoon Therapeutics, Inc. (HARP) - Stock Prices, Stock Peers & Analysis

Home
HARP

Company Name	Harpoon Therapeutics, Inc.
Symbol	HARP
Currency	USD
Price	23.01
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	865,079,358
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	3.11 - 23.21
Industry	Biotechnology
Sector	Healthcare
CEO	Ms. Julie M. Eastland M.B.A.
Website	https://www.harpoontx.com

An error occurred while fetching data.

About Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC)